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Over-the-counter medicines are available without prescription because of their safety and effectiveness, 
to treat minor ailments and symptoms. The objective of the study was to analyze the availability and 
quality of systematic reviews published about nonprescription medicines, identifying the groups for 
which there are gaps in evidence. We identified published articles through the Cochrane Database of 
Systematic Review and MEDLINE, from the start of the database until May 2012, using the search terms 
“nonprescription drugs,” “over the counter,” and “OTC.” We searched for articles that describe systematic 
reviews addressing the efficacy and safety of drugs dispensed without a prescription, according to the 
lists published by the Association of the European Self-Medication Industry and in Brazil, in the clinical 
conditions listed in Groups and Specified Therapeutic Indications. We included 49 articles, 18 articles 
were of moderate quality and 31 of high quality. Of the studies, 74.5% demonstrated efficacy in favor 
of the use of drugs evaluated. Of the 24 studies that evaluated safety, 21% showed evidence unfavorable 
to the drug. Overall, the evidence found in the studies included in the overview is favorable to the use 
of the drugs evaluated. However, there are gaps in evidence for some therapy groups.
Uniterms: Nonprescription medicines. Medicines/safety use. Self-medication. Evidence-based health. 
Os medicamentos isentos de prescrição são disponíveis sem prescrição médica devido a sua efetividade 
e segurança, para tratar sintomas e males menores. O objetivo deste trabalho é revisar a disponibilidade e 
qualidade das revisões sistemáticas publicadas sobre medicamentos isentos de prescrição, identificando os 
grupos para os quais há lacunas de evidência. Foram identificados artigos publicados através da Cochrane 
Database of Systematic Review e MEDLINE (via PubMed) desde o início da base até maio de 2012, 
utilizando os termos “nonprescription drugs,” “over the counter,” “OTC”. Foram procurados artigos 
que descrevessem revisão sistemática abordando a eficácia e segurança dos medicamentos dispensados 
sem prescrição, de acordo com as listas publicadas pela Association of the European Self-Medication 
Industry e no Brasil, nas condições clínicas constantes na lista de Grupos e Indicações Terapêuticas 
Especificadas. Foram incluídos 49 artigos, 18 artigos eram de qualidade moderada e 31 de alta qualidade. 
74,5% dos estudos demonstraram eficácia favorável ao uso do medicamento avaliado. Dos 24 estudos 
que avaliaram segurança, 21% mostraram evidência desfavorável ao uso do medicamento. No geral, a 
evidência encontrada nos estudos incluídos nesta revisão é favorável ao uso dos medicamentos avaliados. 
Entretanto, há grupos terapêuticos para os quais há lacunas na evidência.
Unitermos: Medicamentos isentos de prescrição. Automedicação. Saúde baseada em evidências. 
INTRODUCTION
According to the World Health Organization 
(WHO), over-the-counter (OTC) medicines are drugs 
approved by health authorities to treat minor ailments 
and symptoms. They are available without prescription 
because of their safety and effectiveness, if used in 
accordance with the guidelines available on the package 
inserts and on labels (ABIMIP, 2012). 
In Brazil, this class of drugs is regulated by Board 
Resolution (RDC) of the National Agency for Sanitary 
Surveillance (ANVISA) Number 138 of May 29, 
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2003, which provides for the sale category of products 
(ANVISA, 2003). According to ANVISA, OTC drugs 
can be registered as medicines that meet the conditions of 
the list of Groups and Specified Therapeutic Indications 
(GITE).
The Association of the European Self-Medication 
Industry (AESGP) has lists of nonprescription drugs 
marketed in 36 countries. These lists group the drugs 
according to their chemical, pharmacological, and 
therapeutic characteristics, according to the Anatomical 
Therapeutic Chemical (ATC) Classification System 
established by WHO. In this case, the symbol “OTC” 
means that at least one dosage or form of the drug has the 
legal status of nonprescription medication in some of the 
countries considered (ABIMIP, 2012). 
Although OTC medicines are considered relatively 
safe drugs to be dispensed without a prescription, some 
studies, like the one conducted by Smith et al. (2012), 
call into question their efficacy and safety because of the 
lack of good quality trials. In this sense, evidence-based 
health (EBH) assumes that the behavior of professionals 
in clinical practice should be based on the best scientific 
evidence available at the time (Guaudard, 2008). Thus, 
EBH integrates clinical expertise with the ability to 
analyze and apply rational scientific information (Lopes, 
2000; Manchikanti et al., 2009).
With respect to studies of treatment, systematic 
reviews (SR) are considered currently to provide the 
highest level of evidence in relation to any clinical 
question (El Dib, 2007), as the SR and meta-analyses are 
useful for monitoring important innovations in healthcare. 
A systematic review of systematic reviews (overview) is a 
survey designed primarily to summarize data from several 
reviews, focusing on the effects of clinical interventions 
on a health condition; this is carried out in order to analyze 
the quality of systematic reviews and inform readers how 
failures may influence the results (Higgins, Green, 2011). 
The aim of this study was to analyze the availability 
and quality of systematic reviews published about 
nonprescription medicines, identifying the groups for 
which there are gaps in evidence.
METHODS
Data sources
We performed the overview of systematic reviews, 
following a pre-established protocol, according to the 
PRISMA model (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) (Moher et al., 2009). 
A systematic search was performed on the Cochrane 
Database of Systematic Reviews (CDSR) and MEDLINE 
(via PubMed) over the period from the beginning of the 
database until May 2012. To seek systematic reviews in 
PubMed the following strategy was used for the search: 
(systematic review*[tiab] OR meta-analysis[pt] OR 
meta-analysis[tiab] OR systematic literature review[tiab] 
OR “Cochrane Database Syst Rev”[Journal] OR 
(search*[tiab] AND (medline or embase OR peer-review* 
OR literature OR “evidence-based” OR pubmed OR IPA 
or “international pharmaceutical abstracts”))) NOT 
(letter[pt] OR newspaper article[pt] OR comment[pt]) 
AND hasabstract AND (“Nonprescription Drugs”[Mesh] 
OR “Nonprescription Drugs”[tiab] OR OTC*[tiab] 
OR “over the counter”[tiab]). To format the Cochrane 
Library the following strategy was used: #1 (systematic 
review OR meta-analysis OR “evidence-based”):ti,ab,kw; 
#2 (“Nonprescription Drugs” OR OTC OR “over the 
counter”):ti,ab,kw; #1 AND #2. 
Study selection
After obtaining the articles, all the steps of the 
process were performed by two independent reviewers 
(GCH and AISC), and discrepancies were resolved by 
consensus. In the absence of agreement, the assistance 
of a third reviewer (CJC) was requested. The process for 
selecting the studies followed the PRISMA model (Moher 
et al., 2009): (a) all articles were analyzed based on their 
titles and abstracts (screening);  (b) the articles deemed 
relevant were then fully analyzed by two reviewers, noting 
the inclusion and exclusion criteria (eligibility); and (c) 
articles that met all the criteria were included in the data 
collection (inclusion). Articles that generated questions 
during screening were included and passed through the 
eligibility stage for examination in full. In addition, we 
performed a manual search of references in all articles 
read in full. A search was not performed for unpublished 
articles or articles in conference proceedings. To be 
included, articles had to fulfill the following criteria: there 
was a systematic review, with or without meta-analysis; 
they addressed the efficacy and safety of nonprescription 
medicines considered according to lists released by 
AESGP and OTC drugs in Brazil; the clinical conditions 
were listed in the GITE list. 
The exclusion criteria were: (a) items whose full 
text was not available through the databases or after 
contact with the author; (b) items that did not describe 
or were overviews of systematic reviews; (c) systematic 
reviews that included only prescription drugs; (d) articles 
that evaluated the use of medicinal herbs, vitamins, and 
supplements; (e) items that were defined as systematic 
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reviews, but whose full text did not comply with items 
4, 7 and 9 of the PRISMA checklist (provide an explicit 
statement of questions being addressed with reference 
to participants, interventions, comparisons, outcomes, 
and study design; describe all sources of information in 
the search and date last searched; indicate the selection 
process of the study) (Moher et al., 2009). 
Data extraction
Data were extracted in duplicate and disagreements 
were resolved by consensus between the reviewers. At the 
stage of full reading a  critical evaluation of the studies was 
made in order to verify the methodological quality of the 
reviews and possible sources of bias present in each review 
through the Assessment of Multiple Systematic Reviews 
(AMSTAR) instrument developed by Shea et al. (2009).
The AMSTAR total score was obtained by adding 
one point for each “yes” answer, while any other answer 
did not receive a point. The score ranged from 0 (zero), 
as the worst quality, to 11 (eleven) as the best quality. In 
addition, studies were categorized as proposed by the work 
of Mikton and Butchart (2009) in which a score from 0 to 
4 indicated a review of low quality, from 5 to 8 indicated 
moderate quality, and from 9 to 11 indicated high quality. 
To collect data on efficacy and safety we used a second 
standard instrument developed by the authors. 
RESULTS AND DISCUSSION
By searching the databases, 228 articles of potential 
relevance were found, but only 23 were included. The 
supplementary manual search selected 26 articles, so a 
total of 49 were included in the overview (see flowchart as 
shown in Figure 1). Of these, six articles were published 
in the 90s and others after 2000. The collected data from 
the included studies are shown in Table I.
Three articles were outdated and were therefore 
replaced by updating the manual search (Smith et al., 
2012). Among the articles included by supplementary 
manual search, two were withdrawn from The Cochrane 
Library for lack of update (De Sutter et al., 2009; 
Taverner, Latte, 2009), as recommended by the Cochrane 
Collaboration (Higgins, Green, 2011). 
In order to widen the scope of this overview, we 
included an extensive list of such OTC drugs marketed in 
36 countries and in Brazil. Then, some of the medicines 
included are not OTC drugs in Brazil, for example, 
diclofenac, sumatriptan, and ranitidine are OTC medicines 
in some countries in Europe.
Considering the conditions encountered in clinical 
FIGURE 1 - Flowchart for the selection of systematic reviews 
included in the overview.
studies, it can be seen that most of the articles evaluated 
patients with acute or chronic pain (35.4%) or specifically 
migraine (14.6%). Studies to evaluate the efficacy and 
safety of medicines used to combat pain are extremely 
important, since self-medication in this context is 
a reality. Other clinical conditions assessed in this 
overview were quitting smoking (10.4%), cough (8.3%), 
symptoms of common cold (8.3%), fever and/or pain 
(8.3%), constipation (8.3%), fungal infections (4.2%), 
and dyspepsia (2.1%). Only one study (Jenkins, Costello, 
Hodge, 2004) assessed the safety of the drug against 
various clinical conditions. 
Compared with the GITE list, various therapeutic 
groups and clinical indications have not been evaluated 
by systematic reviews, using the proposed strategy. There 
are, therefore, gaps for groups such as antidiarrheal, 
antispasmodic, antiparasitic, and antiseptic medicines in 
general.
Of the 24 studies that evaluated safety, five (21%) 
showed evidence unfavorable to the drug, due to 
significant side effects presented (Edwards et al., 1999; 
Jenkins; Costello, Hodge, 2004; De Sutter et al., 2009; 
Derry, Moore, 2012; Derry C. et al., 2012). Data of 
security should be considered when dispensing medicines, 
especially in regard to OTC drugs, to encourage rational 
use of these medications.
With regard to studies on the efficacy of OTC 
medicines, 35 articles (74.5%) showed evidence favorable 
for the use of the intervention in at least one of the groups of 
patient studied. Three studies (6.4%) did not show evidence 
favorable to the drug’s efficacy. In one of these, the use of 
antihistamines was not proven effective in the treatment 
of common cold symptoms and showed more side effects 
compared to placebo (De Sutter et al., 2009). Another 
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TABLE I - Main characteristics of systematic reviews on OTC drugs
References Journal
Health problem or 
group of patients 
in study
Design
Studies 
included
Drugs or 
classes of drugs 
evaluated
Meta-
analyses
Evidence 
favorable to 
the drug’s 
efficacy
Evidence 
favorable to 
the drug’s 
safety
Score 
AMSTAR
Koes et al. 
(1997) 
Annals of the 
Rheumatic 
Diseases
Low back pain RCT 26 NSAIDs Yes Yes – 8
Moore et al. 
(1998) 
British Medical 
Journal
Acute and chronic 
pain
RCT 86 Topical NSAIDs Yes Yes Yes 10
Edwards et al. 
(1999) 
Pain
Postoperative 
pain
RCT 72
Acetylsalicylic 
acid
Yes Yes No 8
Van Tulder et 
al. (2003) 
Cochrane 
Database of 
Systematic 
Reviews
Low back pain RCT 30
Carisoprodol; 
chlorzoxazone; 
orphenadrine
Yes Yes – 9
Bjordal et al. 
(2004) 
British Medical 
Journal
Osteoarthritic 
knee pain 
RCT 23 NSAIDs Yes
Yes (short- 
term use)
– 8
Mason et al. 
(2004a) 
British Medical 
Journal
Acute and chronic 
pain
RCT 12
Topical 
rubefacients 
(salicylates)
Yes
Yes (acute 
pain)
Yes 9
Mason et al. 
(2004b) 
BioMed Central 
Family Practice
Acute pain RCT 36 Topical NSAIDs Yes Yes Yes 9
Richy et al. 
(2007) 
International 
Journal of 
Clinical Practice
Rheumatoid 
arthritis 
(outcome pain)
RCT 14 Flurbiprofen Yes Yes Yes 10
Toms et al. 
(2008) 
Cochrane 
Database of 
Systematic 
Reviews
Postoperative 
pain
RCT 51 Paracetamol Yes Yes Yes 9
Derry C. et al. 
(2009a) 
Cochrane 
Database of 
Systematic 
Reviews
Postoperative 
pain
RCT 15 Naproxen Yes Yes Yes 9
Derry C. et al. 
(2009b) 
Cochrane 
Database of 
Systematic 
Reviews
Postoperative 
pain
RCT 72 Ibuprofen Yes Yes Yes 9
Derry P. et al. 
(2009) 
Cochrane 
Database of 
Systematic 
Reviews
Postoperative 
pain
RCT 15 Diclofenac Yes Yes Yes 9
Matthews et 
al. (2009) 
Cochrane 
Database of 
Systematic 
Reviews
Acute and chronic 
pain
RCT 16
Topical 
rubefacients
(salicylates)
Yes No evidence Yes 9
Massey et al. 
(2010) 
Cochrane 
Database of 
Systematic 
Reviews
Acute pain RCT 47 Topical NSAIDs Yes Yes Yes 10
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References Journal
Health problem or 
group of patients 
in study
Design
Studies 
included
Drugs or 
classes of drugs 
evaluated
Meta-
analyses
Evidence 
favorable to 
the drug’s 
efficacy
Evidence 
favorable to 
the drug’s 
safety
Score 
AMSTAR
Moll et al. 
(2011) 
Cochrane 
Database of 
Systematic 
Reviews
Postoperative 
pain
RCT 4 Mefenamic acid Yes Yes – 9
Derry, Moore 
(2012) 
Cochrane 
Database of 
Systematic 
Reviews
Postoperative 
pain
RCT 68
Acetylsalicylic 
acid
Yes Yes No 9
Derry S. et al. 
(2012a) 
Cochrane 
Database of 
Systematic 
Reviews
Chronic 
musculoskeletal 
pain
RCT 34 Topical NSAIDs Yes Yes Yes 9
Oldman et al. 
(2002) 
Pain
Migraine 
headaches 
RCT 48
Sumatriptan; 
acetylsalicylic 
acid + 
metoclopramide; 
naratriptan
Yes Yes – 8
Suthisisang et 
al. (2007) 
The Annals of 
Pharmacotherapy
Migraine 
headaches
RCT 13 Ibuprofen Yes Yes – 10
Derry S. et al. 
(2010) 
Cochrane 
Database of 
Systematic 
Reviews
Migraine 
headaches
RCT 10
Paracetamol 
with or without 
antiemetic 
Yes Yes Yes 9
Kirthi et al. 
(2010) 
Cochrane 
Database of 
Systematic 
Reviews
Migraine 
headaches 
RCT 13
Acetylsalicylic 
acid with 
or without 
antiemetic
Yes Yes Yes 9
Rabbie et al. 
(2010) 
Cochrane 
Database of 
Systematic 
Reviews
Migraine 
headaches 
RCT 9
Ibuprofen with 
or without 
antiemetic
Yes Yes Yes 9
Derry C. et al. 
(2012) 
Cochrane 
Database of 
Systematic 
Reviews
Migraine 
headaches 
RCT 61 Sumatriptan Yes Yes No 9
Derry S. et al. 
(2012b) 
Cochrane 
Database of 
Systematic 
Reviews
Migraine 
headaches
RCT 5
Diclofenac 
with or without 
antiemetic
Yes Yes Yes 9
Hughes et al. 
(2003) 
Tobacco Control
Quit 
smoking
RCT; quasi-
experimental 
trial
7 NRT Yes Yes – 8
Etter, 
Stapleton 
(2006) 
Tobacco Control
Quit 
smoking
RCT 12 NRT Yes Yes – 9
TABLE I - Main characteristics of systematic reviews on OTC drugs (cont.)
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References Journal
Health problem or 
group of patients 
in study
Design
Studies 
included
Drugs or 
classes of drugs 
evaluated
Meta-
analyses
Evidence 
favorable to 
the drug’s 
efficacy
Evidence 
favorable to 
the drug’s 
safety
Score 
AMSTAR
Walsh (2008) 
Drug and 
Alcohol Review
Quit 
smoking
RCT; 
observational 
studies
12 NRT No No – 7
Hughes et al. 
(2011) 
Nicotine 
& Tobacco 
Research
Quit 
smoking
Observational 
studies
18 NRT No Inconclusive – 7
Stead et al. 
(2012) 
Cochrane 
Database of 
Systematic 
Reviews
Quit 
smoking
RCT; quasi-
experimental 
trial
150 NRT Yes Yes – 10
Schroeder, 
Fahey (2002a) 
British Medical 
Journal
Cough in 
adults
RCT 15
Antitussives; 
expectorants; 
mucolytics; 
antihistamine-
decongestant 
combinations; 
other drug 
combinations
No Inconclusive – 9
Schroeder, 
Fahey (2002b) 
Archives of 
Disease in 
Childhood
Cough in 
children
RCT 6
Antitussives; 
expectorants; 
mucolytics; 
antihistamine-
decongestant 
combinations; 
other drug 
combinations
No No – 8
Chang et al. 
(2012) 
Cochrane 
Database of 
Systematic 
Reviews
Cough in adults 
and children
RCT 4
Antitussives; 
mucolytics
Yes Inconclusive – 10
Smith et al. 
(2012) 
Cochrane 
Database of 
Systematic 
Reviews
Cough in adults 
and children
RCT 26
Antitussives; 
expectorants; 
mucolytics; 
antihistamine-
decongestant 
combinations; 
other drug 
combinations
No Inconclusive – 9
Kollar et al. 
(2007) 
Clinical 
Therapeutics
Alleviating nasal 
symptoms of 
common cold
RCT 8 Phenylephrine Yes Yes – 6
De Sutter, et 
al. (2009) 
Cochrane 
Database of 
Systematic 
Reviews
Alleviating nasal 
symptoms of 
common cold
RCT 32 Antihistamines Yes No No 9
TABLE I - Main characteristics of systematic reviews on OTC drugs (cont.)
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Health problem or 
group of patients 
in study
Design
Studies 
included
Drugs or 
classes of drugs 
evaluated
Meta-
analyses
Evidence 
favorable to 
the drug’s 
efficacy
Evidence 
favorable to 
the drug’s 
safety
Score 
AMSTAR
Taverner & 
Latte (2009) 
Cochrane 
Database of 
Systematic 
Reviews
Alleviating nasal 
symptoms of 
common cold
RCT 7
Nasal 
decongestants 
(oral and topical)
Yes
Yes (adults) 
No evidence 
(children)
Yes 9
De Sutter et al. 
(2012) 
Cochrane 
Database of 
Systematic 
Reviews
Alleviating 
symptoms of 
common cold
RCT 27
Oral 
antihistamine-
decongestant-
analgesic 
combinations 
Yes
Yes (adults) 
No evidence 
(children)
– 10
Purssell 
(2002) 
British Journal 
of Community 
Nursing
Fever in children RCT 8
Ibuprofen; 
paracetamol
Yes Yes Yes 8
Perrott et al. 
(2004) 
Archives of 
Pediatrics & 
Adolescent 
Medicine
Fever or pain 
in children
RCT 17
Ibuprofen; 
paracetamol
Yes Yes Yes 8
Meremikwu, 
Oyo-Ita (2009) 
Cochrane 
Database of 
Systematic 
Reviews
Fever in 
children
RCT; quasi-
experimental 
trial
12 Paracetamol Yes Inconclusive – 9
Southey et al. 
(2009) 
Current Medical 
Research and 
Opinion
Fever or pain 
in children
RCT; 
observational 
studies 
36
Ibuprofen; 
paracetamol
Yes – Yes 7
Tramonte et 
al. (1997) 
Journal of 
General Internal 
Medicine
Chronic 
constipation
RCT 36
Bulk-producing 
agents; irritants 
or stimulants; 
osmotically 
active agents; 
surfactants
No Yes - 7
Petticrew 
et al. (1999) 
British Journal of 
General Practice
Chronic 
constipation 
in elderly
RCT 19
Bulk-producing 
agents; irritants 
or stimulants; 
osmotically 
active agents; 
surfactants
No No evidence - 7
Hurdon 
et al. (2000) 
Journal of Pain 
and Symptom 
Management
Chronic 
constipation
RCT 4 Docusate No No evidence - 8
Jones et al. 
(2002) 
Digestive 
Diseases and 
Sciences
Chronic 
constipation
RCT 11
Bulk-producing 
agents; irritants 
or stimulants; 
osmotically 
active agents; 
surfactants
Yes Inconclusive - 7
Hart et al. 
(1999) 
British Medical 
Journal
Fungal infections 
of the skin and 
nails of the feet
RCT 67
Topical 
antifungal
Yes Yes - 8
TABLE I - Main characteristics of systematic reviews on OTC drugs (cont.)
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Evidence 
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the drug’s 
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Crawford, 
Hollis (2007) 
Cochrane 
Database of 
Systematic 
Reviews
Fungal infections 
of the skin and 
nails of the feet
RCT 67
Topical 
antifungal
Yes Yes - 10
Tran et al. 
(2007) 
Alimentary 
Pharmacology & 
Therapeutics
Dyspepsia RCT 14
Histamine-2 
receptor 
antagonists; 
alginates; 
antacids
Yes Yes - 9
Jenkins et al. 
(2004) 
British Medical 
Journal
Induction of 
asthma
RCT 21
Acetylsalicylic 
acid
No - No 8
Abbreviations used: NSAIDs, Non-steroidal anti-inflammatory drugs; RCT, randomized controlled trial; NRT, nicotine replacement therapy. 
TABLE I - Main characteristics of systematic reviews on OTC drugs (cont.)
study evaluating the efficacy of nicotine replacement 
therapy (NRT), without prescription, concluded that the 
superiority of OTC NRT over unaided smoking cessation 
had not been demonstrated convincingly (Walsh, 2008). 
Likewise, the use of medications for coughs were reported 
in children and the results do not demonstrate greater 
efficacy than a placebo, noting the small number of trials 
found (Schroeder, Fahey, 2002b). The other three studies 
related to treatment of coughs showed no good evidence 
in favor of the use of these medicines (Schroeder, Fahey, 
2002a, Chang, Cheng, Chang, 2012; Smith et al., 2012). 
Moreover, some systematic reviews were inconclusive 
or showed no evidence for the use of the drug, suggesting 
more studies.
Concerning the methodological quality of systematic 
reviews, according to the evaluation by the AMSTAR 
instrument, 18 reviews were of moderate quality 
(namely, AMSTAR score of 5-8), 31 were of high quality 
(9-11), and no reviews received a score of 0 to 4, which 
indicates a review of low quality. These data suggest 
that the methodological quality of reviews showed that 
the majority of the published studies are of good quality. 
Moreover, we noticed that all the systematic reviews 
conducted by the Cochrane Collaboration were of high 
quality.
Among the items examined those that mostly did 
not receive the answer “yes” were item numbers 10 and 
11 of the AMSTAR instrument. Item 10 verifies that 
the likelihood of publication bias was assessed, which 
is the tendency for studies with positive results to be 
more often published than studies with negative results 
(Zhou, Obuchowski, McClish, 2002). The possibility of 
the occurrence of this type of bias was not reported in 
42 articles (86%). Item 11 evaluates whether a conflict 
of interest was included in the study; namely, potential 
sources of support should be clearly recognized in both 
the systematic review and in the studies included (Shea et 
al., 2009). Although some studies have reported sources of 
support, there was no explicit statement of this in 32 (65%) 
of the reviews. Similar results were found in the literature 
(Santaguida et al., 2013; Remschmidt, Wichmann, Harder, 
2014), demonstrating the need to improve the description 
of potential conflicts of interest and publication bias.
Relating the quality of studies to clinical conditions, 
we note that all studies on constipation showed moderate 
methodological quality. The same occurred with three 
studies (of four) evaluating fever and/or pain and three 
studies (of five) on quitting smoking. In this case, in 
addition to the items described above, some reviews 
failed in describing other items, such as showing a list 
of excluded studies, describing if the studies undertook 
duplicate study selection and extraction, and rarely 
undertaking meta-analyses.
Regarding the design of the studies found in the 
systematic review, in just one review (Hughes et al., 
2011) did the design not include a randomized clinical 
trial (RCT). According to the author, prospective 
controlled trials are the best way to assess effectiveness by 
determining the effect of therapy on the actual conditions 
of use. Another four studies, in addition to RCTs, 
employed non-randomized studies (Hughes et al., 2003), 
observational studies (Southey, Soares-Weiser, Kleijnen, 
2009), quasi-randomized trials (Meremikwu, Oyo-Ita, 
2009; Stead et al., 2012), and cohort studies (Walsh, 
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2008). The Cochrane Collaboration focuses primarily on 
systematic reviews of randomized clinical trials because 
they are more likely to provide unbiased information than 
other study designs (Higgins, Green, 2011). 
The sale of medicines without the need to present 
a prescription suggests that they are safe and effective. 
Thus, systematic reviews, which correspond to the highest 
level of evidence to evaluate the efficacy and safety of 
nonprescription medicines, are essential contributions 
to their rational use. The present study examined 49 
systematic reviews published up to May 2012, which show 
no evidence of efficacy or safety for at least three of the 
nine clinical conditions assessed. This leads us to think that 
the use of such medicines in certain clinical conditions is 
questionable.
Our overview also presents some limitations. In our 
search strategy, we chose a query with greater specificity, 
instead of a higher sensitivity, for considering the large 
number of OTC drugs marketed. Moreover, many of the 
authors of systematic reviews on OTC medications do not 
use general descriptors such as “nonprescription drugs” 
or “OTC,” which makes the location of these in databases 
difficult. In order to minimize the possible omission of 
studies due to this fact, we conducted a manual search of 
work in the bibliographies of all the studies read in full. 
Finally, we constrained the inclusion of systematic reviews 
only to those health conditions considered treatable with 
OTC medications. This was necessary, considering the 
existence of several reviews involving OTC drugs for 
conditions which require prior medical diagnosis, which 
would be outside the scope of our work. In order to avoid 
biases related to this aspect, we included an extensive list 
of such OTC drugs marketed in 36 countries and in Brazil.
CONCLUSION
The methodological quality of systematic reviews of 
nonprescription medicines, according to studies included, 
is moderate to high. Thus, the quality of the available 
evidence in these is good enough for their use in clinical 
practice. The evidence found in the studies included in 
the overview is favorable to the use of most of the drugs 
evaluated, like topical antifungal, analgesics, and anti-
inflammatory drugs. However, some systematic reviews 
were inconclusive or showed no evidence for the use of the 
drug, suggesting more studies, as in the case of nicotine 
replacement therapy without prescription, medications for 
coughs, and chronic constipation. Then, there are therapy 
groups for which there are gaps in evidence, necessitating 
the need for studies in this area.
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